• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

[Ann Intern Med.] Asymptomatic, low risk women should not be screened for ovarian cancer – new USPSTF statement

bys25qthea
September 13, 2012
in Obstetrics, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Image: CC/James Heilman. Ovarian cancer on CT scan. 

Primer: Ovarian cancer, while uncommon, is the most lethal gynecologic malignancy. In 2004, the U.S. Preventive Services Task Force (USPSTF) decided that the harms of ovarian cancer screening outweighed its benefits and classified the testing as grade D, recommending that physicians refrain from screening all asymptomatic women without known genetic susceptibility for ovarian cancer. As medicine continues to advance, the USPSTF decided to review newer literature with the goal of determining whether or not to change the previously established grade D recommendation.

This study: Through a 2008 review of observations of the harms of screening, combined with a 2011 review of randomized, controlled trials, the USPSTF drew the following conclusions from the studies. We highlighted key points below:

The Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial (2009 and 2011) – A randomized, controlled trial including 78,216 women assigned to either CA-125 serum tumor marker or transvaginal ultrasonography annual screening groups or a control group undergoing care without screening were followed for 13 years. The use of either screening methods did not reduce ovarian cancer mortalities when compared to those undergoing usual care (118 vs. 100 deaths, relative risk 1.18 [CI: 0.82-1.71]).

The PLCO, the Schizuoka Cohort Study of Ovarian Cancer Screening (2008) and the ongoing United Kingdom Collaborative Trial of Ovarian Cancer Screening(2005 and 2009) (both randomized trials) found that the large amount of false positives secondary to ovarian cancer screening methods’ low positive predictive values. This often leads patients to undergo unnecessary invasive procedures and surgeries for treatment and diagnostic confirmation.

There is not much evidence regarding the value of annual screening for high risk individuals, defined as those with BRCA1 and BRCA2 mutations, hereditary nonpolyposis colorectal cancer, or a family history of ovarian cancer. The USPSTF is looking to a continuing prospective cohort study, the United Kingdom Familial Ovarian Cancer Screening Study, to elucidate the benefit of screening high-risk patients.

In sum: The USPSTF reaffirmed its grade D recommendation against annual screening of asymptomatic, low-risk women for ovarian cancer stating that the harms of testing outweigh the potential benefits. The organization encourages high-risk women to seek additional genetic counseling prior to ovarian cancer screening and recognizes that its regulations are similar to those of other major health organizations.

RELATED REPORTS

Evaluation of medical school parental leave policies in the United States

Adjuvant S-1 increases short-term survival in patients with resected biliary tract cancer

Risk of hydroxychloroquine retinopathy increases with longer use and higher dosage

Click to read the study in the Annals of Internal Medicine

© 2012 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. DISCALIMER: Posts are not medical advice and are not intended as such. Please see a healthcare professional if you seek medical advice.

Previous Post

[CIRCULATION] NSAID use after heart attacks associated with increased coronary risk, death

Next Post

[JAMA] Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events

RelatedReports

Preterm birth associated with lower high school academic performance
Psychiatry

Evaluation of medical school parental leave policies in the United States

February 1, 2023
Fatty liver disease may independently predict high-risk coronary disease
Chronic Disease

Adjuvant S-1 increases short-term survival in patients with resected biliary tract cancer

February 1, 2023
Blindness and visual impairment decreasing worldwide
Chronic Disease

Risk of hydroxychloroquine retinopathy increases with longer use and higher dosage

February 1, 2023
Ultrasound enhances gastrointestinal absorption of drugs at low frequencies
Emergency

Nirmatrelvir-ritonavir combination reduces hospitalization and mortality in COVID-19

February 1, 2023
Next Post

[JAMA] Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events

[BMJ] Tranexamic acid reduces mortality in traumatic bleeding

[CMAJ] Influenza vaccination coverage across ethnic groups

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Evaluation of medical school parental leave policies in the United States
  • Adjuvant S-1 increases short-term survival in patients with resected biliary tract cancer
  • Risk of hydroxychloroquine retinopathy increases with longer use and higher dosage
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options